| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.005 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.15 | 0.01 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.01 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.01 |